(VIANEWS) – Shares of NYXOAH (BEL 20: NYXH.BR) fell by a staggering 10.8% to €7.10 at 14:22 EST on Wednesday, after three consecutive sessions in a row of losses. BEL 20 is dropping 0.51% to €3,806.44, following the last session’s downward trend. This seems, up to now, a somewhat negative trend exchanging session today.
NYXOAH’s last close was €7.96, 53.5% under its 52-week high of €17.12.
About NYXOAH
Nyxoah S.A., a medical technology company, focuses on the development and commercialization of solutions to treat sleep disordered breathing conditions. The company offers Genio system, a CE-Marked, patient-centric, and hypoglossal neurostimulation therapy to treat moderate to severe obstructive sleep apnea. Nyxoah S.A. was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium.
Earnings Per Share
As for profitability, NYXOAH has a trailing twelve months EPS of €-1.1.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -23.22%.
More news about NYXOAH (NYXH.BR).
